Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a milk protein help dialysis patients fight anemia?

NCT ID NCT07706582

Ongoing Disease control Sponsor: Beni-Suef University Source: ClinicalTrials.gov ↗

First seen Jul 15, 2026 · Last updated Jul 21, 2026 · Updated 3 times

Summary

This study tests whether oral lactoferrin, a protein found in milk, can improve anemia and bone health in adults with end-stage kidney disease on dialysis. Participants receive either lactoferrin, IV iron, or both for three months, alongside their usual anemia medication. The goal is to see if lactoferrin can raise hemoglobin levels and improve markers of bone health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
oral lactoferrin, a dietary supplement, and IV iron dextran
What this could lead to
If effective, lactoferrin could offer a gentler, oral option to manage anemia and bone health in dialysis patients.
What could go wrong
This is a small, early-phase trial, so results may not be conclusive. Lactoferrin may not work as well as standard IV iron.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESRD (END STAGE RENAL DISEASE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic renal failure syndrome end stage renal failure iron deficiency anemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ESRD (END STAGE RENAL DISEASE) IRON DEFICIENCY ANEMIA (IDA)

Contacts and locations

Locations

  • Theodor Bilharz Research Institute (TBRI)

    Giza, El-Nile Street, Imbaba, Warrak El Hader, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.